Compare RBB & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RBB | CGC |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 451.0M | 467.3M |
| IPO Year | 2017 | 2023 |
| Metric | RBB | CGC |
|---|---|---|
| Price | $26.49 | $0.93 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $22.00 | N/A |
| AVG Volume (30 Days) | 73.9K | ★ 3.6M |
| Earning Date | 04-20-2026 | 05-29-2026 |
| Dividend Yield | ★ 2.68% | N/A |
| EPS Growth | 24.49 | ★ 84.17 |
| EPS | ★ 1.25 | N/A |
| Revenue | $5,167,000.00 | ★ $12,759,000.00 |
| Revenue This Year | $20.50 | $8.27 |
| Revenue Next Year | $6.90 | $15.68 |
| P/E Ratio | $21.10 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $16.74 | $0.84 |
| 52 Week High | $28.24 | $2.38 |
| Indicator | RBB | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 49.30 | 37.30 |
| Support Level | $25.41 | $0.91 |
| Resistance Level | $28.06 | $1.15 |
| Average True Range (ATR) | 0.51 | 0.03 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 60.51 | 1.01 |
RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.